Answers are grounded in this paper and cite their sources.
Understanding the pharmacokinetics of prodrug and metaboliteThis tutorial explains the pharmacokinetics of a prodrug and its active metabolite (or parent drug) using a two-step, consecutive, first-order irreversible reaction as a basic model for prodrug metabolism.In this model, the prodrug is metabolized and produces the parent drug, which is subsequently eliminated.The mathematical expressions for pharmacokinetic parameters were derived step by step.In addition, we visualized these expressions to help understand the relationship between pharmacokinetic parameters easily.For the elimination rate-limited and formation rate-limited metabolism, we analyzed the plasma drug concentration versus time curve of a prodrug administered intravenously.When a prodrug is administered orally, it undergoes complicate processes of absorption, distribution, metabolism, and excretion.To understand these processes for metabolites, Cummings and Martin published results on the excretion and accrual of drug metabolites in 1963.[4] This provides the basis for the pharmacokinetics of drug and its metabolites and can be readily applied to study the pharmacokinetics of prodrug.Since then, many theoretical analyses and reviews, related to prodrug pharmacokinetics, have been published.[5-10]A thorough understanding of prodrug kinetics is daunting and may be achieved using sophisticated physiologically based pharmacokinetic (PBPK) modeling.[11,12] To get some insight pertinent to prodrug kinetics, we consider a simple scheme for the fate of a prodrug (P) after intravenous administration (Fig. 1).A fraction of the prodrug (f) is metabolized and produces a parent drug (D) with a first-order formation rate constant, k f(D) .The drug (D) may be further metabolized to a daughter metabolite (DM 1 ) or excreted.The elimination rate constant of the parent drug, k el(D) , is expressed by the sum of the formation rate constant of the daughter metabolite, k f(DM1) , and the urinary excretion rate constant, k ex(D) .More than one metabolite may be formed with a formation rate constant, k f(PM2) , and then excreted with a rate constant, k ex(PM2) .Otherwise, a fraction of the drug is excreted into urine as unchanged form (P) with a rate constant, k ex(P) .The overall TUTORIAL
No takes yet. Share an insight, caveat, or question.
Young‐Ran Yoon (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: